Tamiflu (Genentech, Inc.)
Welcome to the PulseAid listing for the Tamiflu drug offered from Genentech, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genentech, Inc. |
NON-PROPRIETARY NAME: | oseltamivir phosphate |
SUBSTANCE NAME: | OSELTAMIVIR PHOSPHATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1999-10-27 |
END MARKETING DATE: | 0000-00-00 |
Tamiflu HUMAN PRESCRIPTION DRUG Details:
Item Description | Tamiflu from Genentech, Inc. |
LABELER NAME: | Genentech, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 75(mg/1) |
START MARKETING DATE: | 1999-10-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0004-0800_60278de2-6767-4f6e-9935-47bd8d365464 |
PRODUCT NDC: | 0004-0800 |
APPLICATION NUMBER: | NDA021087 |
Other OSELTAMIVIR PHOSPHATE Pharmaceutical Manufacturers / Labelers: